Probiotix Health (AQSE:PBX) Total Long-Term Assets: £0.19 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AQSE:PBX Probiotix Health PLC AQSE:PBX
27 GF Score
Price £0.11
GF Value £0.09
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Probiotix Health Total Long-Term Assets?

Probiotix Health AQSE:PBX 27 Total Long-Term Assets is £0.19 Mil as of Dec. 2025. GuruFocus rates AQSE:PBX with a GF Score™ of 27/100 and a GF Value™ of £0.09 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Probiotix Health's Total Long-Term Assets for the quarter that ended in Dec. 2025 was £0.19 Mil.

Probiotix Health Total Long-Term Assets Historical Data

* Premium members only.

The historical data trend for Probiotix Health's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Probiotix Health Total Long-Term Assets Chart

Probiotix Health Annual Data
Trend Dec18 Dec19 Dec20 Dec22 Dec23 Dec24 Dec25
Total Long-Term Assets
Get a 7-Day Free Trial 0.36 0.32 0.30 0.24 0.19

Probiotix Health Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.30 0.28 0.24 0.22 0.19
AQSE:PBX
27GF Score
Probiotix Health PLC AQSE:PBX
Total Long-Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Probiotix Health Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Frequently Asked Questions Learn more about Total Long-Term Assets →
What does a Total Long-Term Assets of £0.19 Mil mean?
Probiotix Health (AQSE:PBX) has a Total Long-Term Assets of £0.19 Mil as of Dec. 2025. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Probiotix Health and its competitors.
Is Probiotix Health's Total Long-Term Assets too high?
Probiotix Health's current Total Long-Term Assets is £0.19 Mil. Overall, Probiotix Health has a GF Score™ of 27/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Probiotix Health's Total Long-Term Assets compare to VRTX and REGN?
Probiotix Health's Total Long-Term Assets of £0.19 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Long-Term Assets for a Biotechnology company?
A good Total Long-Term Assets depends on the Biotechnology industry context. However, Total Long-Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Long-Term Assets mean?
A high Total Long-Term Assets can signal that a stock is expensive relative to its fundamentals. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Probiotix Health and its competitors. Probiotix Health's current Total Long-Term Assets is £0.19 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Probiotix Health stock overvalued right now?
Based on GuruFocus' analysis, Probiotix Health (AQSE:PBX) is currently considered Modestly Overvalued. The stock's GF Value™ is £0.09, compared to a current price of £0.11 — trading 16.7% above its estimated fair value. The current Total Long-Term Assets is £0.19 Mil. Probiotix Health's overall GF Score™ is 27/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Long-Term Assets calculated?
Total Long-Term Assets is calculated from a company's financial statements. For Probiotix Health (AQSE:PBX), the current Total Long-Term Assets is £0.19 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Probiotix Health (AQSE:PBX) Overvalued in 2026?

Based on GuruFocus' analysis, Probiotix Health stock appears to be overvalued. The current stock price of £0.11 is trading 16.7% above its estimated GF Value™ of £0.09. GuruFocus considers Probiotix Health to be Modestly Overvalued.

Key valuation signals for AQSE:PBX:

  • Total Long-Term Assets: £0.19 Mil
  • GF Value™: £0.09 vs. price of £0.11 (16.7% above fair value)
  • GF Score™: 27/100 with 4 warning signs

No single metric tells the full story. See the AQSE:PBX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Probiotix Health Business Description

Address Nostell Business Estate, First Floor Zucchi Suite, Wakefield, GBR, WF4 1AB
Probiotix Health PLC is a life sciences company that develops probiotics to tackle cardiovascular disease and other lifestyle conditions that are affecting growing numbers of people across the world. The company has one class of business, in three geographical areas, being that of identifying and developing microbial strains, compounds and formulations for use in the nutraceutical industry. Its geographical segments include the United Kingdom, the United States, and the Rest of the World. It generates the majority of its revenue from the United States.
27GF Score

Get the complete analysis for AQSE:PBX

Total Long-Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.11
Price
£0.09
GF Value